President Makes NCAB Appointments

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 8
Volume 5
Issue 8

WASHINGTON--President Clin-ton has reappointed Barbara K. Rimer, DrPH, to a second 2-year term as chair of the National Cancer Advisory Board (NCAB) and appointed Richard J. Boxer, MD, professor of family and community medicine, Medical College of Wisconsin, Milwaukee, to a full 6-year term. Dr. Boxer had served on the board for a year to complete the term of Paul Calabresi, MD, who resigned to join the President's Cancer Panel.

WASHINGTON--President Clin-ton has reappointed Barbara K. Rimer,DrPH, to a second 2-year term as chair of the National CancerAdvisory Board (NCAB) and appointed Richard J. Boxer, MD, professorof family and community medicine, Medical College of Wisconsin,Milwaukee, to a full 6-year term. Dr. Boxer had served on theboard for a year to complete the term of Paul Calabresi, MD, whoresigned to join the President's Cancer Panel.

The President also appointed four new members: Frederick P. Li,MD, head of the Division of Cancer Epidemiology, Dana-Farber CancerInstitute; Ivor Royston, MD, president and CEO of the Sidney KimmelCancer Center, San Diego; Ellen L. Stovall, executive directorof the National Coalition for Cancer Survivorship; and SandraMillon-Underwood, PhD, associate professor, University of Wisconsin,Milwaukee.

Related Videos
Video 8 - "Closing Thoughts on the Future of NSCLC"
Video 7 - "Molecular Testing: Key Takeaways on Next Generation Sequencing in NSCLC "
Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD
Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD
Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD
Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD
Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD
video 8 - "Treatment Landscape for NSCLC With EGFR Exon 20 Insertion Mutations"
Video 7 - "Second-Line Treatment of Patients With EGFR-Mutated NSCLC"
A panel of 5 experts on liver cancer